|
|
||
|
Nr. 2 - 2. Quartal 2001 Methodological Investigations in the
Prevention of Skin Graft Rejection Using the CD95L (FasLigand) System
– Preliminary Step in the Engineering of Immune-Privileged Skin
Allografts Introduction: Skin grafting of the severely
burned patient may cause various problems, such as limitation of
autologous skin donor sites, infection and sepsis. The prolonged time
period necessary for cultivation of autologous epidermal cells in turn
could further aggravate already existing complications of these
patients. The development of allogeneic skin grafts with reduced
immunogenicity could be a possible solution for these problems.
CD95-ligand, a transmembrane protein of the tumor-necrosis-factor
superfamily, is known to induce apoptosis via cross-linking of
CD95-expressing activated cytotoxic t-cells. Co-transplantation of
CD95-ligand may prolong graft survival. As Sertoli cells
constitutively express the Fas–Ligand, we investigated the survival
of transplanted Sertoli cells without the presence of a stabilizing
matrix as well as using a collagen-glycosaminoglycane-matrix as a
dermal substitute in the rat model.
LEW rats receiving DA testicular tissue and DA skin
grafts served as controls. Biopsies were taken on post-operative days
12 and 24. Key words: Allogeneic skin grafts, graft rejection, CD95 / CD95L, apoptosis, sertoli cells, collagen-glycosaminoglycane matrix (integraä ) Prof. Dr. Peter M. Vogt
|